CLINICAL_TRIALS
trial_result
· 2012-08-28
Clinical Trial Update: Safety and Efficacy Study of LymphoStat-B (Belimumab) in Subjects With Systemic Lupus Erythematosus (SLE) [Phase 2]
Summary
A Phase 2 safety and efficacy study of belimumab (LymphoStat-B) in systemic lupus erythematosus has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Human Genome Sciences Inc. | Conditions: Lupus Erythematosus, Systemic | Phase 2 | Status: COMPLETED | Results posted: 2012-08-28